Franklin

Regulating Pharmaceuticals in Europe.

Author/Creator:
Mossialos, Elias.
Publication:
Berkshire : McGraw-Hill Education, 2004.
Format/Description:
Book
1 online resource (390 pages)
Series:
UK Higher Education OUP Humanities and Social Sciences Health and Social Welfare Ser.
UK Higher Education OUP Humanities and Social Sciences Health and Social Welfare Ser.
Status/Location:
Loading...

Options
Location Notes Your Loan Policy

Details

Other records:
Subjects:
Pharmaceutical industry -- Europe.
Drugs -- Law and legislation -- Europe.
Drugs -- Prescribing -- Europe.
Pharmaceutical policy -- Europe.
Form/Genre:
Electronic books.
Summary:
The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. This book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.
Contents:
Front Cover
Half title
Title
Copyright
Contents
List of boxes, figures and tables
List of contributors
Series editors' introduction
Foreword
Preface
Acknowledgements
Chapter 1 Regulating pharmaceuticals in Europe: an overview
Chapter 2 The politics of pharmaceuticals in the European Union
Chapter 3 The European Community dimension: coordinating divergence
Chapter 4 The role of the EMEA in regulating pharmaceutical products
Chapter 5 Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector
Chapter 6 Regulating pharmaceutical prices in the European Union
Chapter 7 Reimbursement of pharmaceuticals in the European Union
Chapter 8 Good prescribing practice
Chapter 9 Patients and their medicines
Chapter 10 Financial incentives and prescribing
Chapter 11 Regulating pharmaceutical distribution and retail pharmacy in Europe
Chapter 12 Hospital pharmacies
Chapter 13 Influencing demand for drugs through cost sharing
Chapter 14 The off-patent pharmaceutical market
Chapter 15 The over-the-counter pharmaceutical market
Chapter 16 The implications of pharmacogenetics and pharmacogenomics for drug development and health care
Chapter 17 Should we pay for lifestyle drugs?
Chapter 18 Alternative medicines in Europe
Chapter 19 The pharmaceutical sector and regulation in the countries of Central and Eastern Europe
Chapter 20 Access to pharmaceuticals and regulation in the Commonwealth of Independent States
Chapter 21 A framework for containing costs fairly
Index
Back cover.
Notes:
Description based on publisher supplied metadata and other sources.
Contributor:
Mrazek, Monique.
Walley, Tom.
Other format:
Print version: Mossialos, Elias Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality
ISBN:
9780335226559
9780335214655
OCLC:
191935038